Trial · NCT00301262
Impact Of Viagra On Sexual Satisfaction Of Men With Mild Erectile Dysfunction Who Are Sexually Dissatisfied
NCT00301262, Phase 4, Completed, Pfizer's Upjohn has merged with Mylan to form Viatris Inc.; results first posted 2008-12-09
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Impact Of Viagra On Sexual Satisfaction Of Men With Mild Erectile Dysfunction Who Are Sexually Dissatisfied. Trials, record NCT00301262. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00301262
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Impact Of Viagra On Sexual Satisfaction Of Men With Mild Erectile Dysfunction Who Are Sexually Dissatisfied
- NCT number
- NCT00301262
- Status
- Completed
- Phases
- Phase 4
- Enrollment
- 183 participants, actual
- Lead sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Conditions
- Impotence
- Interventions
- Viagra (Sildenafil citrate)
- First posted
- 2006-03-10
- Last updated
- 2021-02-01
- Results first posted
- 2008-12-09
Source ClinicalTrials.gov
Registered outcomes49
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) Index at the End of the DB Treatment (Week 8) | Week 8 | adjusted mean : Possible scores for the EDITS Index range from 0 (extremely low treatment satisfaction) to 100 (extremely high treatment satisfaction). |
| Secondary | Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) Index | Week 8, Week 14 | Possible scores for the EDITS Index range from 0 (extremely low treatment satisfaction) to 100 (extremely high treatment satisfaction). |
| Secondary | Change From Baseline to End of Double-Blind Phase (Week 8) in Patient Reported Erectile Function Assessment (PREFA) Total Score | Week 8 | adjusted mean change; PREFA Total Score: 8 = worst; 32 = best. |
| Secondary | Patient Reported Erectile Function Assessment (PREFA) Total Score | Week 8, Week 14 | PREFA Total Score: 8 = worst, 32 = best. |
| Secondary | Change From Baseline to End of DB Phase (Week 8) in International Index of Erectile Function (IIEF) Domain Scores- Erectile Function | Week 8 | adjusted mean change - Possible total scores for IIEF-EF range from 1 (worst) to 30 (best). |
| Secondary | Change From Baseline to End of DB Phase (Week 8) in International Index of Erectile Function (IIEF) Domain Scores- Orgasmic Function | Week 8 | adjusted mean change - Possible total scores for IIEF-OF range from 0 (worst) to 10 (best). |
| Secondary | Change From Baseline to End of DB Phase (Week 8) in International Index of Erectile Function (IIEF) Domain Scores- Sexual Desire | Week 8 | adjusted mean change - Possible total scores for IIEF-SD range from 2 (worst) to 10 (best). |
| Secondary | Change From Baseline to End of DB Phase (Week 8) in International Index of Erectile Function (IIEF) Domain Scores- Intercourse Satisfaction | Week 8 | adjusted mean - Possible total scores for IIEF-IS range from 0 (worst) to 15 (best). |
| Secondary | Change From Baseline to End of DB Phase (Week 8) in International Index of Erectile Function (IIEF) Domain Scores- Overall Satisfaction | Week 8 | adjusted mean change - Possible total scores for IIEF-OS range from 2 (worst) to 10 (best). |
| Secondary | International Index of Erectile Function (IIEF) Domain Scores- Erectile Function | Week 8, Week 14 | Possible total scores for IIEF-EF range from 1 (worst) to 30 (best). |
1 to 10 of 49Source ClinicalTrials.gov
See all 49 registered outcomesOutcomes49
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) Index at the End of the DB Treatment (Week 8) | Week 8 | number of subjects in the Full Analysis Set (FAS) population with an observation | scores on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) Index | Week 8, Week 14 | number of subjects in the FAS population with an observation | scores on a scale | MEAN |
| SECONDARY | Change From Baseline to End of Double-Blind Phase (Week 8) in Patient Reported Erectile Function Assessment (PREFA) Total Score | Week 8 | number of subjects in the FAS population with an observation | scores on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Patient Reported Erectile Function Assessment (PREFA) Total Score | Week 8, Week 14 | number of subjects in the FAS population with an observation | scores on a scale | MEAN |
| SECONDARY | Change From Baseline to End of DB Phase (Week 8) in International Index of Erectile Function (IIEF) Domain Scores- Erectile Function | Week 8 | number of subjects in the FAS population with an observation | scores on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Change From Baseline to End of DB Phase (Week 8) in International Index of Erectile Function (IIEF) Domain Scores- Orgasmic Function | Week 8 | number of subjects in the FAS population with an observation | scores on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Change From Baseline to End of DB Phase (Week 8) in International Index of Erectile Function (IIEF) Domain Scores- Sexual Desire | Week 8 | number of subjects in the FAS population with an observation | scores on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Change From Baseline to End of DB Phase (Week 8) in International Index of Erectile Function (IIEF) Domain Scores- Intercourse Satisfaction | Week 8 | number of subjects in the FAS population with an observation | scores on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Change From Baseline to End of DB Phase (Week 8) in International Index of Erectile Function (IIEF) Domain Scores- Overall Satisfaction | Week 8 | number of subjects in the FAS population with an observation | scores on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | International Index of Erectile Function (IIEF) Domain Scores- Erectile Function | Week 8, Week 14 | number of subjects in the FAS population with an observation | scores on a scale | MEAN |
1 to 10 of 49Source ClinicalTrials.gov
See all 49 outcomesResults by group186
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) Index at the End of the DB Treatment (Week 8) | DB Viagra | 80.27 | Standard Error 2.329 | scores on a scale | |
| Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) Index at the End of the DB Treatment (Week 8) | DB Placebo | 62.15 | Standard Error 2.524 | scores on a scale | |
| Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) Index | DB Viagra Week 8 | 79.21 | Standard Deviation 19.646 | scores on a scale | |
| Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) Index | DB Viagra/OL Viagra Week 14 | 84.12 | Standard Deviation 17.220 | scores on a scale | |
| Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) Index | DB Placebo Week 8 | 61.64 | Standard Deviation 22.752 | scores on a scale | |
| Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) Index | DB Placebo/OL Viagra Week 14 | 87.42 | Standard Deviation 15.124 | scores on a scale | |
| Change From Baseline to End of Double-Blind Phase (Week 8) in Patient Reported Erectile Function Assessment (PREFA) Total Score | DB Viagra | 3.97 | Standard Error 0.498 | scores on a scale | |
| Change From Baseline to End of Double-Blind Phase (Week 8) in Patient Reported Erectile Function Assessment (PREFA) Total Score | DB Placebo | 2.21 | Standard Error 0.536 | scores on a scale | |
| Patient Reported Erectile Function Assessment (PREFA) Total Score | DB Viagra Week 8 | 28.54 | Standard Deviation 3.468 | scores on a scale | |
| Patient Reported Erectile Function Assessment (PREFA) Total Score | DB Viagra /OL Viagra Week 14 | 29.58 | Standard Deviation 2.988 | scores on a scale |
1 to 10 of 186Source ClinicalTrials.gov
See all 186 results by groupParticipant flow12
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Double Blind Phase (DB) | STARTED | DB Viagra / OL Viagra | 94 | |
| Double Blind Phase (DB) | STARTED | DB Placebo/OL Viagra | 82 | |
| Double Blind Phase (DB) | COMPLETED | DB Viagra / OL Viagra | 84 | |
| Double Blind Phase (DB) | COMPLETED | DB Placebo/OL Viagra | 69 | |
| Double Blind Phase (DB) | NOT COMPLETED | DB Viagra / OL Viagra | 10 | |
| Double Blind Phase (DB) | NOT COMPLETED | DB Placebo/OL Viagra | 13 | |
| Open Label Phase (OL) | STARTED | DB Viagra / OL Viagra | 83 | |
| Open Label Phase (OL) | STARTED | DB Placebo/OL Viagra | 69 | |
| Open Label Phase (OL) | COMPLETED | DB Viagra / OL Viagra | 79 | |
| Open Label Phase (OL) | COMPLETED | DB Placebo/OL Viagra | 67 |
1 to 10 of 12Source ClinicalTrials.gov
See all 12 participant flowAdverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 28892218 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT00301262
GET https://conductscience.org/api/trials/v1/NCT00301262/registered?page=2